Our speakers

Divya Madaan, Director - Technology Management and Transformation, Sun Life Global Solutions

Divya Madaan, Director - Special Initiatives, Digital Enterprise, Asia, Sun life

Divya Sehgal, Director, India Value Fund Advisors

Divya Sehgal joined IVFA in 2010 and is based in Mumbai.

Prior to IVFA, Divya was the Chief Operating Officer of Apollo Health Street (AHS), a leading healthcare outsourcing firm with worldwide operations. Divya was a founder of AHS and led it to be among the top five firms in its space globally. As COO, Divya managed a global team of executives with responsibility for business strategy, sales and marketing, organization development and service delivery.

Prior to Apollo, Divya served as a consultant at McKinsey, as an investment banker at ANZ and as an entrepreneur at Emedlife. His consulting work at McKinsey involved portfolio and business strategy, acquisition advisory and operational restructuring across a range of clients. His work in the corporate finance team at ANZ Investment bank included M&A and valuation advisory. His entrepreneurial stint involved setting up Emedlife, one of the first corporate healthcare advisory firms in India, raising capital from the Dabur group, growing it to leadership status and then eventually merging it with the Apollo group.

Divya holds a Bachelor’s degree in Electrical Engineering from Indian Institute of Technology, Delhi and a Post Graduate Diploma in Management from Indian Institute of Management, Bangalore.

Diwakar Dadoo, Fund Manager & HEAD – Emerging Markets, Brand Capital

Diwakar is a founding member of Brand Capital. Since its inception in 2005,he helped Times Group to set up & grow Brand Capital (earlier called Times Private Treaties)with the help of significant Private Equity Investments across sectors, and across regions.He has a track record of building and mentoring teams and organizations that succeed & outperform.

Diwakar is a Fellow Chartered Accountant, apprenticed at Ernst & Young and received his MBA (Marketing & Finance) from Faculty of Management Studies, University of Delhi.

Diwakar has more than 17 years of experience in Investment Banking, Fund Management, Consulting, Brand Development & Management, International Trade, Marketing & Sales having worked with Corporates and some of the top Consulting Firms, in India and abroad.

Diwakar is currently pursuing his Doctorate in Private Equity and regularly contributes by sharing his thoughts at VC / PE conferences, brand and industry forums. He enjoys reading, traveling, watching theatre, supporting art and spending time with the family.

Diwakar Dayal, Managing Director, SentinelOne

Dominic Goh, Principal, Harbourvest Partners

Dominic Goh joined HarbourVest in 2012 and focuses on secondary investments. This includes analyzing, structuring, and monitoring a wide range of secondary transaction types.

Dominic was previously at Coller Capital where he evaluated secondary opportunities, and contributed to deal sourcing and fundraising efforts in Asia. Prior to that, he was an investment banking associate at ABN AMRO London in the Financial Institutions Group.

Dominic received a BSc (first class honours) in Accounting & Finance from the London School of Economics and Political Science in 2005. Dominic is fluent in Mandarin.

Donald Chan, Managing Director, Asia Pacific, CDP

Dr A.Velumani, Founder, Thyrocare Technologies Ltd

Dr A Velumani, an Ex BARC research scientist is the promotor of Thyrocare Technologies Limited. It was started in 1996, after completing his PhD in Thyroid Pathophysiology and Immunodiagnostics. Today Thyrocare is the industry leader, trend setter and innovators in Indian Diagnostic industry. A company with a network of more than 10,000 Service Centers across the country, its laboratory is certified ISO 9001-2000, accredited by NABL and to keep it ready to take on the global market, in 2007, it has been accredited by the College of American Pathologists (CAP), a global accrediting organisation.

Thyrocare network is vast enough to process in a day 50,000 investigations as on date and it has a capacity to process 5,00,000 investigations per day in its current facilities in Mumbai. This unique, single laboratory model could take on the entire country market, using its innovative and intelligent logistics.  Using an air cargo driven logistics for incoming specimens, the laboratory receives every night, same night, before midnight, from 90% of Indian geography. With a backend prowess in IT, this webserver controlled operations deliver reports every morning in every part of the country.

With an impressive volume driven profitablity and focussed, dynamic and scalable model, now it looks at global market and it beleives that it can operate as a global hub for the clinical chemistry segment. Invitro success can be also tried in in-vivo business if ideal partners are identified. It has a compounded annualgrowth of 25% and is doing currently 50 crores of turnover.

Dr Amit Kakar, Managing Partner and Head of Asia, Novo Holdings Equity Asia Pte Ltd

Dr Amit Varma, MD, Healthcare Religare Enterprises Limited

Dr Amit Varma currently operates as President Health Care, Religare Enterprises and Director, Critical Care Medicine, Fortis Escorts group of Hospitals, India. Having completed his MBBS and MD from University of Delhi, Dr Varma further completed his residency from the State University of New York. Thereafter he went on to pursue fellowships in critical care at the University of Pittsburgh Medical Center, and sub specialized in cardiac critical care at the Cleveland Clinic. Alongside this, he also attended courses for an Executive MBA at the University of Chicago.

After almost a decade in USA, Dr Varma began his professional journey in India at the Manipal Heart Foundation in Bangalore. He subsequently moved on to the Narayan Hrudayalaya Hospital as the consultant- in-charge of Critical Care. Early in 2003, Dr Varma joined Fortis Healthcare, where he has and continues to perform multiple administrative and clinical roles. He currently runs the integrated critical care services for Fortis Healthcare ICU network, which today comprises of a strong three-Hundred beds and helps in ormulation of Medical Strategy.

At Religare from 2009, Dr Varma is actively engaged in all healthcare initiatives of the company, playing an advisory and steering role, overlooking and further initiating all healthcare related businesses, providing medical expertise, insight and credibility in all healthcare related verticals such as Health Insurance venture, Healthcare IT, Super Religare Labs and Religare Wellness. He also sits on the Board and Investment committee of the 125$ million Milestone Religare Private Equity fund which is investing domestically in the healthcare and education fields.